Coronavirus and kidney disease

Our coronavirus and kidney disease hub pulls together all our work related to Covid-19.

Get the latest information about Covid-19 kidney research we are funding and how the charity has been affected by the pandemic.

Get answers to some of the questions we are asked most frequently about the Covid-19 vaccines.

Our work on Covid-19

Find out about our research and work into coronavirus and kidney disease that your generous donations are helping to fund.

Staying safe as lockdown eases

The Kidney Charities Together Group have teamed up to provide you with the information you need to stay safe.

Covid-19 vaccines and kidney disease

Take a look at our Covid-19 vaccine information, find out how vaccines help protect you and read our frequently asked questions.

Can a tapeworm drug protect high risk kidney patients from Covid-19?

We are helping to fund a clinical trial to find out if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it.

High Throughput Screening STP multi-pipetting.

New study will reveal how well Covid-19 vaccines protect dialysis patients

Kidney Research UK, the National Kidney Federation (NKF), Kidney Wales and the PKD Charity have joined forces to fund a new research study to discover how well Covid-19 vaccines work in people who go to hospital for their dialysis treatment (haemodialysis).

Support for healthcare professionals

Our colleagues at the UK Kidney Association have just released new guidance for healthcare professionals looking after clinically extremely vulnerable kidney patients, which we are happy to endorse.

Staying safe at work

People shouldn’t feel like they are being forced into Covid unsafe workplaces so we have joined a charity coalition to create a resource to help. Share this letter with your employer if you are anxious.